Browse by Title

Type here to filter the list

D
DAD Catheter: An Angioplasty Apparatus for Facilitating Accurate Placement of a Lumen Stent for Dilating Ostial Stenosis. This Includes Arcuate Low-Pressure Balloon Segment(s) Connected at a Distal Catheter or to a Stent

Nader Dakak, MD (he/him/his) – Intersect Vascular LLC ### 2233573###Speaker###Medical director###Intersect Vascular LLC###
Speaker: Nader Dakak, MD (he/him/his) – Intersect Vascular LLC
### he/him/his
DANGER

Gregg W. Stone, MD, FACC, MSCAI (he/him/his) – Mount Sinai ### 163300###Moderator###Physician###Mount Sinai###
Moderator: Gregg W. Stone, MD, FACC, MSCAI (he/him/his) – Mount Sinai
### he/him/his @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Moderator###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
###
DANGER Trial | Why DANGER will meet the Endpoint

Babar Basir, DO – Henry Ford Hospital ### 657365###Speaker###Directory of Acute Mechanical Circulatory Support###Henry Ford Hospital ###
Speaker: Babar Basir, DO – Henry Ford Hospital
###
DANGER Trial | Why DANGER will NOT meet the Endpoint

George W. Vetrovec, MD, MACC, MSCAI – VCU Pauley Heart Center ### 163331###Speaker###Professor Emeritus###VCU Pauley Heart Center###
Speaker: George W. Vetrovec, MD, MACC, MSCAI – VCU Pauley Heart Center
###
DANGER Trial Study Design

Gregg W. Stone, MD, FACC, MSCAI (he/him/his) – Mount Sinai ### 163300###Speaker###Physician###Mount Sinai###
Speaker: Gregg W. Stone, MD, FACC, MSCAI (he/him/his) – Mount Sinai
### he/him/his
DCB as First-Line Treatment for Complex PCI

Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare ### 242825###Speaker###consultant Cardiologist###Fondazione Ricerca e Innovazione Cardiovascolare###
Speaker: Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare
### he/him/his
DCB Below the Knee: Will it Work?

Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – ACV Centers ### 163223###Speaker###CEO###ACV Centers###
Speaker: Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – ACV Centers
### he/him/his
DCB FOR CORONARY APPLICATIONS

Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare ### 242825###Moderator###consultant Cardiologist###Fondazione Ricerca e Innovazione Cardiovascolare###
Moderator: Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare
### he/him/his @@@ Bruno Scheller, MD – University of Saarland ### 163284###Moderator###Professor of Clinical and Experimental Interventional Cardiology###University of Saarland###
Moderator: Bruno Scheller, MD – University of Saarland
###
DCB for De Novo Coronary Disease

Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare ### 242825###Speaker###consultant Cardiologist###Fondazione Ricerca e Innovazione Cardiovascolare###
Speaker: Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare
### he/him/his
DCBs: Comparing DCBs: Drug Design Matters – Clinical

Bruno Scheller, MD – University of Saarland ### 163284###Speaker###Professor of Clinical and Experimental Interventional Cardiology###University of Saarland###
Speaker: Bruno Scheller, MD – University of Saarland
###
DCBs: Comparing DCBs: Drug Design Matters – Preclinical

Aloke V. Finn, MD – CVPath ### 181604###Speaker###Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland###CVPath###
Speaker: Aloke V. Finn, MD – CVPath
###
DCBs for Coronary ISR: Technical Considerations and Concerns

Aloke V. Finn, MD – CVPath ### 181604###Speaker###Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland###CVPath###
Speaker: Aloke V. Finn, MD – CVPath
###
DCBs Other Indications (CTO, Bifurcations, etc)

Tuomas Rissanen, MD, PhD – North Karelia Central Hospital ### 2203642###Speaker###Head of Heart Center###North Karelia Central Hospital###
Speaker: Tuomas Rissanen, MD, PhD – North Karelia Central Hospital
###
Debate
Debate
Debate
Debate
DEBATE #1 – RADIAL SHOULD BE USED IN ALL CASES IF FEASIBLE
Debate #1 – Vote

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Moderator###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Moderator: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Manju Bengaluru Jayanna, MD, MS – Bryn Mawr Medical Specialists, Mainline Health ### 2262451###Panel Discussant###Interventional Cardiologist ###Bryn Mawr Medical Specialists, Mainline Health###
Panel Discussant: Manju Bengaluru Jayanna, MD, MS – Bryn Mawr Medical Specialists, Mainline Health
### @@@ Kalyan Chitturi, DO – MedStar Washington Hospital Center ### 1872216###Panel Discussant###Fellow###MedStar Washington Hospital Center###
Panel Discussant: Kalyan Chitturi, DO – MedStar Washington Hospital Center
### @@@ Priyanka Ghosh, DO – Guthrie Robert Packer Hospital ### 1546540###Panel Discussant###Cardiology Fellow###Guthrie Robert Packer Hospital###
Panel Discussant: Priyanka Ghosh, DO – Guthrie Robert Packer Hospital
### @@@ Sandeep Jalli, DO – Largo Medical Center ### 2262452###Panel Discussant###Interventional Cardiology Fellow###Largo Medical Center###
Panel Discussant: Sandeep Jalli, DO – Largo Medical Center
### @@@ Najam Saqib, MD (he/him/his) – University of Cincinnati ### 1859222###Panel Discussant###Interventional Cardiology###University of Cincinnati ###
Panel Discussant: Najam Saqib, MD (he/him/his) – University of Cincinnati
### he/him/his
DEBATE #2 – TO SEE OR NOT TO SEE, THAT IS THE QUESTION: A DEBATE ON IMAGING IN CONTEMPORARY PCI
Debate #2 – Vote

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Moderator###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Moderator: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Manju Bengaluru Jayanna, MD, MS – Bryn Mawr Medical Specialists, Mainline Health ### 2262451###Panel Discussant###Interventional Cardiologist ###Bryn Mawr Medical Specialists, Mainline Health###
Panel Discussant: Manju Bengaluru Jayanna, MD, MS – Bryn Mawr Medical Specialists, Mainline Health
### @@@ Kalyan Chitturi, DO – MedStar Washington Hospital Center ### 1872216###Panel Discussant###Fellow###MedStar Washington Hospital Center###
Panel Discussant: Kalyan Chitturi, DO – MedStar Washington Hospital Center
### @@@ Priyanka Ghosh, DO – Guthrie Robert Packer Hospital ### 1546540###Panel Discussant###Cardiology Fellow###Guthrie Robert Packer Hospital###
Panel Discussant: Priyanka Ghosh, DO – Guthrie Robert Packer Hospital
### @@@ Sandeep Jalli, DO – Largo Medical Center ### 2262452###Panel Discussant###Interventional Cardiology Fellow###Largo Medical Center###
Panel Discussant: Sandeep Jalli, DO – Largo Medical Center
### @@@ Najam Saqib, MD (he/him/his) – University of Cincinnati ### 1859222###Panel Discussant###Interventional Cardiology###University of Cincinnati ###
Panel Discussant: Najam Saqib, MD (he/him/his) – University of Cincinnati
### he/him/his
DEBATE #3 – THE FIRST LINE OF MECHANICAL SUPPORT FOR HIGH-RISK PCI SHOULD BE…
Debate #3 – Vote

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Moderator###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Moderator: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Manju Bengaluru Jayanna, MD, MS – Bryn Mawr Medical Specialists, Mainline Health ### 2262451###Panel Discussant###Interventional Cardiologist ###Bryn Mawr Medical Specialists, Mainline Health###
Panel Discussant: Manju Bengaluru Jayanna, MD, MS – Bryn Mawr Medical Specialists, Mainline Health
### @@@ Kalyan Chitturi, DO – MedStar Washington Hospital Center ### 1872216###Panel Discussant###Fellow###MedStar Washington Hospital Center###
Panel Discussant: Kalyan Chitturi, DO – MedStar Washington Hospital Center
### @@@ Priyanka Ghosh, DO – Guthrie Robert Packer Hospital ### 1546540###Panel Discussant###Cardiology Fellow###Guthrie Robert Packer Hospital###
Panel Discussant: Priyanka Ghosh, DO – Guthrie Robert Packer Hospital
### @@@ Sandeep Jalli, DO – Largo Medical Center ### 2262452###Panel Discussant###Interventional Cardiology Fellow###Largo Medical Center###
Panel Discussant: Sandeep Jalli, DO – Largo Medical Center
### @@@ Najam Saqib, MD (he/him/his) – University of Cincinnati ### 1859222###Panel Discussant###Interventional Cardiology###University of Cincinnati ###
Panel Discussant: Najam Saqib, MD (he/him/his) – University of Cincinnati
### he/him/his
DEBATE #4 – PHYSIOLOGY MODALITY
Debate #4 – Vote

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Moderator###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Moderator: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Yousif Al-Saiegh, MD – Lankenau Medical Center ### 2262456###Panel Discussant###Cardiovascular Fellow ###Lankenau Medical Center###
Panel Discussant: Yousif Al-Saiegh, MD – Lankenau Medical Center
### @@@ Kalyan Chitturi, DO – MedStar Washington Hospital Center ### 1872216###Panel Discussant###Fellow###MedStar Washington Hospital Center###
Panel Discussant: Kalyan Chitturi, DO – MedStar Washington Hospital Center
### @@@ Utsab R. Panta, MD – University of Louisville ### 2262457###Panel Discussant###Interventional cardiology fellow###University of Louisville ###
Panel Discussant: Utsab R. Panta, MD – University of Louisville
### @@@ Mohammed Salih, MD – Baylor University Medical Center/ The Heart Hospital Plano ### 1872215###Panel Discussant###General Cardiology Fellow###Baylor University Medical Center/ The Heart Hospital Plano###
Panel Discussant: Mohammed Salih, MD – Baylor University Medical Center/ The Heart Hospital Plano
###
DEBATE #5 – EMBOLIC PROTECTION DEVICES SHOULD BE USED IN…
Debate #5 – Vote

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Moderator###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Moderator: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Yousif Al-Saiegh, MD – Lankenau Medical Center ### 2262456###Panel Discussant###Cardiovascular Fellow ###Lankenau Medical Center###
Panel Discussant: Yousif Al-Saiegh, MD – Lankenau Medical Center
### @@@ Kalyan Chitturi, DO – MedStar Washington Hospital Center ### 1872216###Panel Discussant###Fellow###MedStar Washington Hospital Center###
Panel Discussant: Kalyan Chitturi, DO – MedStar Washington Hospital Center
### @@@ Utsab R. Panta, MD – University of Louisville ### 2262457###Panel Discussant###Interventional cardiology fellow###University of Louisville ###
Panel Discussant: Utsab R. Panta, MD – University of Louisville
### @@@ Mohammed Salih, MD – Baylor University Medical Center/ The Heart Hospital Plano ### 1872215###Panel Discussant###General Cardiology Fellow###Baylor University Medical Center/ The Heart Hospital Plano###
Panel Discussant: Mohammed Salih, MD – Baylor University Medical Center/ The Heart Hospital Plano
###
DEBATE #6 – THE FIRST LINE OF THERAPY FOR FUNCATIONAL MR SHOULD BE…
Debate #6 – Vote

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Moderator###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Moderator: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Yousif Al-Saiegh, MD – Lankenau Medical Center ### 2262456###Panel Discussant###Cardiovascular Fellow ###Lankenau Medical Center###
Panel Discussant: Yousif Al-Saiegh, MD – Lankenau Medical Center
### @@@ Kalyan Chitturi, DO – MedStar Washington Hospital Center ### 1872216###Panel Discussant###Fellow###MedStar Washington Hospital Center###
Panel Discussant: Kalyan Chitturi, DO – MedStar Washington Hospital Center
### @@@ Utsab R. Panta, MD – University of Louisville ### 2262457###Panel Discussant###Interventional cardiology fellow###University of Louisville ###
Panel Discussant: Utsab R. Panta, MD – University of Louisville
### @@@ Mohammed Salih, MD – Baylor University Medical Center/ The Heart Hospital Plano ### 1872215###Panel Discussant###General Cardiology Fellow###Baylor University Medical Center/ The Heart Hospital Plano###
Panel Discussant: Mohammed Salih, MD – Baylor University Medical Center/ The Heart Hospital Plano
###
Debate: My Patient Has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for Pharmacology Escalation

Judith Veis, MD – Medstar Washington Hospital Center ### 188316###Speaker###Section Director, Nephrology###Medstar Washington Hospital Center###
Speaker: Judith Veis, MD – Medstar Washington Hospital Center
###
Debate: My Patient Has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for Renal Denervation

Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center ### 653443###Speaker###Director of Vascular Intervention###Beth Israel Deaconess Medical Center###
Speaker: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center
###
Decadal Analysis Of Acute Myocardial Infarction Mortality Trends In The African American Population In The United States (1999-2020)

Muhammad Umer Riaz Gondal, MD – Reading Hospital ### 2234264###Speaker###Internal Medicine Resident###Reading Hospital###
Speaker: Muhammad Umer Riaz Gondal, MD – Reading Hospital
###
Decisions for Escalation and De-Escalation

Mohit Pahuja, MD – University of Oklahoma Medical Center ### 1519862###Speaker###Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology###University of Oklahoma Medical Center###
Speaker: Mohit Pahuja, MD – University of Oklahoma Medical Center
###
Deep Dive to TRISCEND II Study

Vinod Thourani, MD, FACC, FACS – Piedmont Heart Institute ### 163315###Speaker###Professor of Surgery, Chairman of Cardiovascular Surgery###Piedmont Heart Institute###
Speaker: Vinod Thourani, MD, FACC, FACS – Piedmont Heart Institute
###
Deep Learning Model For Real-time Catheter Tracking From Fluoroscopy

Bobak Mosadegh, PhD (he/him/his) – Weill Cornell Medicine ### 2234349###Speaker###Director, Dalio Institute of Cardiovascular Imaging###Weill Cornell Medicine###
Speaker: Bobak Mosadegh, PhD (he/him/his) – Weill Cornell Medicine
### he/him/his
Deep Venous Arterialization: Surgical Versus Endovascular

Richard F. Neville, MD – INOVA, Fairfax, VIrginia ### 163229###Speaker###Associate Director, Heart and Vascular Institute Chairman, Department of Surgery###INOVA, Fairfax, VIrginia###
Speaker: Richard F. Neville, MD – INOVA, Fairfax, VIrginia
###
De-Escalation Strategies: Switch or Discontinuation?

Davide Capodanno, MD, PhD – Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania ### 309175###Speaker###Full Professor###Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania###
Speaker: Davide Capodanno, MD, PhD – Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania
###
Defining Non-Inferiority for DEB Versus DES: Update SELUTION ISR and De Novo Programs

Donald E. Cutlip, MD, FACC (he/him/his) – Beth Israel Deaconess Medical Center ### 163071###Speaker###Vice Chair, Department of Medicine###Beth Israel Deaconess Medical Center###
Speaker: Donald E. Cutlip, MD, FACC (he/him/his) – Beth Israel Deaconess Medical Center
### he/him/his
“DEI 101”: Fundamental Constructs for Prospective Trials

Michael R. Jaff, DO – Boston Scientific Corporation ### 163148###Speaker###Chief Medical Officer###Boston Scientific Corporation###
Speaker: Michael R. Jaff, DO – Boston Scientific Corporation
###
"DEI 101" for MCS Device Studies - What Do We Do, How Do We Define "Success"?

Roberta Chapman ### 2273353###Speaker#########
Speaker: Roberta Chapman
###
DEI Metrics for CV device research -- How do we Measure “Success”?

Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Speaker###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Speaker: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
###
Design Features of the ACURATE Platform

Helge Moellmann, MD – St.-Johannes-Hospital Dortmund ### 483624###Speaker###Director Dept. of Cardiology###St.-Johannes-Hospital Dortmund###
Speaker: Helge Moellmann, MD – St.-Johannes-Hospital Dortmund
###
Designing a Clinical Trial for Mixed Aortic Disease and in Moderate- and Low-Risk Patients: Is It Feasible?

David J. Cohen, MD, FSCAI – Cardiovascular Research Foundation ### 163057###Speaker###Director of Clinical and Outcomes Research###Cardiovascular Research Foundation###
Speaker: David J. Cohen, MD, FSCAI – Cardiovascular Research Foundation
###
DEVICE INNOVATIONS FOR HEART FAILURE

Jennifer L. Carter, DPT (she/her/hers) – Medstar Washington Hospital Center ### 1810713###Moderator###Senior Physical Therapist###Medstar Washington Hospital Center###
Moderator: Jennifer L. Carter, DPT (she/her/hers) – Medstar Washington Hospital Center
### she/her/hers
Device Retrieval After Unsuccessful PFO Closure

Felipe Hernández, MD – Hospital La Luz ### 1857274###Speaker###Interventional Cardiologist###Hospital La Luz###
Speaker: Felipe Hernández, MD – Hospital La Luz
###
DEVICE SELECTION FOR CARDIOGENIC SHOCK: A DEEP DIVE TO MULTIPLE OPTIONS

Babar Basir, DO – Henry Ford Hospital ### 657365###Moderator###Directory of Acute Mechanical Circulatory Support###Henry Ford Hospital ###
Moderator: Babar Basir, DO – Henry Ford Hospital
### @@@ Ben Kenigsberg, MD (he/him/his) – MedStar Washington Hospital Center ### 900615###Moderator###Co-Director Medical Cardiovascular ICU###MedStar Washington Hospital Center###
Moderator: Ben Kenigsberg, MD (he/him/his) – MedStar Washington Hospital Center
### he/him/his
DEVICE-BASED HYPERTENSION THERAPIES IN US AND JAPAN

Misti Malone, PhD (she/her/hers) – FDA ### 201905###Moderator###Asst Director, PIDT###FDA###
Moderator: Misti Malone, PhD (she/her/hers) – FDA
### she/her/hers @@@ Hiroyoshi Yokoi, MD – Fukuoka Sanno Hospital ### 193503###Moderator###Director###Fukuoka Sanno Hospital###
Moderator: Hiroyoshi Yokoi, MD – Fukuoka Sanno Hospital
###
Device-Based Therapies for Heart Failure in the Modern Era: Innovation in Heart Failure Trial Designs

Ori Ben-Yehuda, MD (he/him/his) – University of California, San Diego ### 163024###Speaker###Professor of Medicine###University of California, San Diego###
Speaker: Ori Ben-Yehuda, MD (he/him/his) – University of California, San Diego
### he/him/his
DEVICES TO PREVENT CORONARY OBSTRUCTION AND ENABLERS OF LIVE MANAGEMENT

Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center ### 185869###Moderator###Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease###Georgetown University and MedStar Washington Hospital Center###
Moderator: Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center
### @@@ Michael Wholey, MD, MBA, FSCAI – University Texas San Antonio ### 163344###Moderator###Interventional Radiology ###University Texas San Antonio###
Moderator: Michael Wholey, MD, MBA, FSCAI – University Texas San Antonio
###
Devices to Reverse Remodel the Dilated Failing Heart

Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation ### 163047###Speaker###Director: Heart Failure, Hemodynamics and MCS Research###Cardiovascular Research Foundation###
Speaker: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation
###
DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISM

S. Jay Mathews, MD – Manatee Memorial Hospital ### 1432175###Moderator###Director, Cardiac Cath Lab, PERT, & Structural Heart###Manatee Memorial Hospital###
Moderator: S. Jay Mathews, MD – Manatee Memorial Hospital
### @@@ Rachel Rosovsky, MD, MPH – Massachusetts General Hospital ### 435371###Moderator###Associate Professor, Harvard Medical school###Massachusetts General Hospital###
Moderator: Rachel Rosovsky, MD, MPH – Massachusetts General Hospital
### @@@ Andrew SP Sharp, MD – University Hospital of Wales ### 952803###Moderator###Consultant Cardiologist###University Hospital of Wales###
Moderator: Andrew SP Sharp, MD – University Hospital of Wales
###
Dib UltraNav Transseptal Catheter System

Nabil Dib, MD, MSc, FESC – Mercy Gilbert Medical Center/Dignity Health ### 939332###Speaker###Director Cardiovascular Research###Mercy Gilbert Medical Center/Dignity Health###
Speaker: Nabil Dib, MD, MSc, FESC – Mercy Gilbert Medical Center/Dignity Health
###
Dietary and Pharmacologic Approaches to Hypertension Management in 2024 – What’s New and What’s Changed

Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC (he/him/his) – University of Louisville ### 302894###Speaker###Chair, Department of Medicine###University of Louisville###
Speaker: Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC (he/him/his) – University of Louisville
### he/him/his
Differences In Hemodynamic Performance And Modality Measurements Between Self-expanding Versus Balloon-expanding Valves In ViV-tavi Patients With Failed Aortic Bioprosthesis (fab-tavi Study)

Sraman Chatterjee, BSc – Erasmus University Medical Center ### 2234355###Speaker###Researcher at the Department of Interventional Cardiology###Erasmus University Medical Center###
Speaker: Sraman Chatterjee, BSc – Erasmus University Medical Center
###
Differentiating DK Crush from DK Culotte

Tanveer Rab, MD, FACC, FSCAI – Emory University ### 196705###Speaker### Professor###Emory University###
Speaker: Tanveer Rab, MD, FACC, FSCAI – Emory University
###
DIGITAL PARTNERSHIPS AND MARKETING INVESTMENTS – WHAT WILL IT TAKE TO ADOPT SOFTWARE DEVICES?

Mona Advani, M.Sc., MBA (she/her/hers) – CardioMed Device Consultants ### 2215265###Moderator###Principal Regulatory Consultant###CardioMed Device Consultants###
Moderator: Mona Advani, M.Sc., MBA (she/her/hers) – CardioMed Device Consultants
### she/her/hers @@@ Richard E. Galgon, MD, MS (he/him/his) – CardioMed Device Consultants, LLC ### 2234030###Moderator###Principal Consultant###CardioMed Device Consultants, LLC###
Moderator: Richard E. Galgon, MD, MS (he/him/his) – CardioMed Device Consultants, LLC
### he/him/his
Dinner
Dinner
Dinner
Dinner
Dinner
Dinner
Dire Consequence Of Lipid Emulsion Therapy And VA-ECMO

Joseph D. Abraham, MD – The Jewish Hospital - Cincinnati, OH ### 2234222###Speaker###Internal Medicine Resident Physician ###The Jewish Hospital - Cincinnati, OH###
Speaker: Joseph D. Abraham, MD – The Jewish Hospital - Cincinnati, OH
###
Direct Carotid Access For Acute Stroke Intervention

Mehmet Cilingiroglu, MD – UTHSCSA ### 291690###Speaker###Professor###UTHSCSA###
Speaker: Mehmet Cilingiroglu, MD – UTHSCSA
###
Direct Carotid Access For Treatment Of Acute Ischemic Stroke Interventions

Mehmet Cilingiroglu, MD – UTHSCSA ### 291690###Speaker###Professor###UTHSCSA###
Speaker: Mehmet Cilingiroglu, MD – UTHSCSA
###
Discussion

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Panel Moderator###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Panel Moderator: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
### @@@ Wesley Lane ### 2239767###Panel Discussant#########
Panel Discussant: Wesley Lane
### @@@ Paul D. Mahoney, MD, FACC, FSCAI – ECU Health ### 478297###Panel Discussant###Chief, Interventional Cardiology, Director, Structural Heart Program###ECU Health###
Panel Discussant: Paul D. Mahoney, MD, FACC, FSCAI – ECU Health
### @@@ Ibrahim Sultan, MD – University of Pittsburgh Medical Center ### 1543790###Panel Discussant###Associate Professor of Cardiothoracic Surgery###University of Pittsburgh Medical Center###
Panel Discussant: Ibrahim Sultan, MD – University of Pittsburgh Medical Center
###
Discussion

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Panel Moderator###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Panel Moderator: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
### @@@ Wesley Lane ### 2239767###Panel Discussant#########
Panel Discussant: Wesley Lane
### @@@ Paul D. Mahoney, MD, FACC, FSCAI – ECU Health ### 478297###Panel Discussant###Chief, Interventional Cardiology, Director, Structural Heart Program###ECU Health###
Panel Discussant: Paul D. Mahoney, MD, FACC, FSCAI – ECU Health
### @@@ Ibrahim Sultan, MD – University of Pittsburgh Medical Center ### 1543790###Panel Discussant###Associate Professor of Cardiothoracic Surgery###University of Pittsburgh Medical Center###
Panel Discussant: Ibrahim Sultan, MD – University of Pittsburgh Medical Center
###
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital ### 256841###Panel Moderator###Catheterization Laboratory Director & Deputy Head of Cardiology###King Fahd Armed Forces Hospital###
Panel Moderator: Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital
### @@@ Kimberly A. Skelding, MD, FACC FAHA FSCAI (she/her/hers) – RWJ Barnabas Health Jersey City ### 178176###Panel Moderator###Division Chief of Cardiovascular Services###RWJ Barnabas Health Jersey City###
Panel Moderator: Kimberly A. Skelding, MD, FACC FAHA FSCAI (she/her/hers) – RWJ Barnabas Health Jersey City
### she/her/hers @@@ J. Dawn Abbott, MD – Brown University ### 465924###Panel Discussant###Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University ###Brown University###
Panel Discussant: J. Dawn Abbott, MD – Brown University
### @@@ Nina Goodheart, MBA – Structural Heart & Aortic - Medtronic ### 2235111###Panel Discussant###SVP & President###Structural Heart & Aortic - Medtronic###
Panel Discussant: Nina Goodheart, MBA – Structural Heart & Aortic - Medtronic
### @@@ Jennifer Jones-McMeans, PhD (she/her/hers) – Abbott Vascular, Inc. ### 2253427###Panel Discussant###Divisional Vice President, Global Clinical Affairs###Abbott Vascular, Inc.###
Panel Discussant: Jennifer Jones-McMeans, PhD (she/her/hers) – Abbott Vascular, Inc.
### she/her/hers @@@ Tenley Koepnick (she/her/hers) – Edwards Lifesciences ### 2238577###Panel Discussant###Vice President, Global Clinical Affairs###Edwards Lifesciences###
Panel Discussant: Tenley Koepnick (she/her/hers) – Edwards Lifesciences
### she/her/hers @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Discussant###Professor of Medicine ###Yale School of Medicine###
Panel Discussant: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
###
Discussion

Suzanne J. Baron, MD, MSc – Massachusetts General Hospital ### 195293###Panel Moderator###Interventional Cardiologist###Massachusetts General Hospital###
Panel Moderator: Suzanne J. Baron, MD, MSc – Massachusetts General Hospital
### @@@ Allison Dupont, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 880570###Panel Discussant###Interventional Cardiologist###Northside Cardiovascular Institute###
Panel Discussant: Allison Dupont, MD, FACC, FSCAI – Northside Cardiovascular Institute
### @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Moderator###Professor of Medicine ###Yale School of Medicine###
Panel Moderator: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
### @@@ Srihari S. Naidu, MD, FSCAI – Westchester Medical Center ### 163225###Panel Discussant###Director, Cath Labs and HCM Program###Westchester Medical Center###
Panel Discussant: Srihari S. Naidu, MD, FSCAI – Westchester Medical Center
### @@@ Olga Toleva, MD, MPH – Georgia Heart Institute ### 1534232###Panel Discussant###Lead of Advanced Coronary Physiology Program###Georgia Heart Institute###
Panel Discussant: Olga Toleva, MD, MPH – Georgia Heart Institute
### @@@ Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 1222247###Panel Discussant###Attending Physician###Northside Cardiovascular Institute###
Panel Discussant: Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute
###
Discussion

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital ### 256841###Panel Moderator###Catheterization Laboratory Director & Deputy Head of Cardiology###King Fahd Armed Forces Hospital###
Panel Moderator: Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital
### @@@ Kimberly A. Skelding, MD, FACC FAHA FSCAI (she/her/hers) – RWJ Barnabas Health Jersey City ### 178176###Panel Moderator###Division Chief of Cardiovascular Services###RWJ Barnabas Health Jersey City###
Panel Moderator: Kimberly A. Skelding, MD, FACC FAHA FSCAI (she/her/hers) – RWJ Barnabas Health Jersey City
### she/her/hers @@@ J. Dawn Abbott, MD – Brown University ### 465924###Panel Discussant###Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University ###Brown University###
Panel Discussant: J. Dawn Abbott, MD – Brown University
### @@@ Nina Goodheart, MBA – Structural Heart & Aortic - Medtronic ### 2235111###Panel Discussant###SVP & President###Structural Heart & Aortic - Medtronic###
Panel Discussant: Nina Goodheart, MBA – Structural Heart & Aortic - Medtronic
### @@@ Jennifer Jones-McMeans, PhD (she/her/hers) – Abbott Vascular, Inc. ### 2253427###Panel Discussant###Divisional Vice President, Global Clinical Affairs###Abbott Vascular, Inc.###
Panel Discussant: Jennifer Jones-McMeans, PhD (she/her/hers) – Abbott Vascular, Inc.
### she/her/hers @@@ Tenley Koepnick (she/her/hers) – Edwards Lifesciences ### 2238577###Panel Discussant###Vice President, Global Clinical Affairs###Edwards Lifesciences###
Panel Discussant: Tenley Koepnick (she/her/hers) – Edwards Lifesciences
### she/her/hers @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Discussant###Professor of Medicine ###Yale School of Medicine###
Panel Discussant: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
###
Discussion

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital ### 256841###Panel Moderator###Catheterization Laboratory Director & Deputy Head of Cardiology###King Fahd Armed Forces Hospital###
Panel Moderator: Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital
### @@@ Kimberly A. Skelding, MD, FACC FAHA FSCAI (she/her/hers) – RWJ Barnabas Health Jersey City ### 178176###Panel Moderator###Division Chief of Cardiovascular Services###RWJ Barnabas Health Jersey City###
Panel Moderator: Kimberly A. Skelding, MD, FACC FAHA FSCAI (she/her/hers) – RWJ Barnabas Health Jersey City
### she/her/hers @@@ J. Dawn Abbott, MD – Brown University ### 465924###Panel Discussant###Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University ###Brown University###
Panel Discussant: J. Dawn Abbott, MD – Brown University
### @@@ Nina Goodheart, MBA – Structural Heart & Aortic - Medtronic ### 2235111###Panel Discussant###SVP & President###Structural Heart & Aortic - Medtronic###
Panel Discussant: Nina Goodheart, MBA – Structural Heart & Aortic - Medtronic
### @@@ Jennifer Jones-McMeans, PhD (she/her/hers) – Abbott Vascular, Inc. ### 2253427###Panel Discussant###Divisional Vice President, Global Clinical Affairs###Abbott Vascular, Inc.###
Panel Discussant: Jennifer Jones-McMeans, PhD (she/her/hers) – Abbott Vascular, Inc.
### she/her/hers @@@ Tenley Koepnick (she/her/hers) – Edwards Lifesciences ### 2238577###Panel Discussant###Vice President, Global Clinical Affairs###Edwards Lifesciences###
Panel Discussant: Tenley Koepnick (she/her/hers) – Edwards Lifesciences
### she/her/hers @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Discussant###Professor of Medicine ###Yale School of Medicine###
Panel Discussant: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
###
Discussion

Rasha Al-Lamee, MA, MD, PhD – Imperial College London ### 195289###Panel Moderator###Interventional Cardiology Consultant###Imperial College London###
Panel Moderator: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
### @@@ Arasi Maran, MD – Medical University of South Carolina ### 469065###Panel Moderator###Associate Professor###Medical University of South Carolina###
Panel Moderator: Arasi Maran, MD – Medical University of South Carolina
### @@@ Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital ### 1880527###Panel Discussant###Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati ###The Christ Hospital###
Panel Discussant: Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital
### she/her/hers @@@ Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center ### 318231###Panel Discussant###Director of Intravascular Imaging###St. Francis Hospital - The Heart Center###
Panel Discussant: Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center
### @@@ Angela M. Taylor, MD, MS, MBA – University of Virginia ### 555069###Panel Discussant###Professor ###University of Virginia###
Panel Discussant: Angela M. Taylor, MD, MS, MBA – University of Virginia
###
Discussion

Suzanne J. Baron, MD, MSc – Massachusetts General Hospital ### 195293###Panel Moderator###Interventional Cardiologist###Massachusetts General Hospital###
Panel Moderator: Suzanne J. Baron, MD, MSc – Massachusetts General Hospital
### @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Moderator###Professor of Medicine ###Yale School of Medicine###
Panel Moderator: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
### @@@ Allison Dupont, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 880570###Panel Discussant###Interventional Cardiologist###Northside Cardiovascular Institute###
Panel Discussant: Allison Dupont, MD, FACC, FSCAI – Northside Cardiovascular Institute
### @@@ Srihari S. Naidu, MD, FSCAI – Westchester Medical Center ### 163225###Panel Discussant###Director, Cath Labs and HCM Program###Westchester Medical Center###
Panel Discussant: Srihari S. Naidu, MD, FSCAI – Westchester Medical Center
### @@@ Olga Toleva, MD, MPH – Georgia Heart Institute ### 1534232###Panel Discussant###Lead of Advanced Coronary Physiology Program###Georgia Heart Institute###
Panel Discussant: Olga Toleva, MD, MPH – Georgia Heart Institute
### @@@ Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 1222247###Panel Discussant###Attending Physician###Northside Cardiovascular Institute###
Panel Discussant: Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute
###
Discussion

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai, New York ### 163212###Panel Moderator###Director, The Women’s Heart and Vascular Center at Mount Sinai Heart Director, The Center for Interventional Cardiovascular Research and Clinical Trials Endowed Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes Professor of Medicine (Cardiology) Professor of Population Health Science and Policy ###Icahn School of Medicine at Mount Sinai, New York###
Panel Moderator: Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai, New York
### @@@ Renuka Jain, MD – Aurora St. Luke's ### 2235124###Panel Discussant###Director of Echocardiography ###Aurora St. Luke's###
Panel Discussant: Renuka Jain, MD – Aurora St. Luke's
### @@@ Puja B. Parikh, MD, MPH – Stony Brook University Renaissance School of Medicine ### 195305###Panel Discussant###Director, Transcatheter Aortic Valve Replacement Program; Associate Professor of Medicine with Tenure###Stony Brook University Renaissance School of Medicine###
Panel Discussant: Puja B. Parikh, MD, MPH – Stony Brook University Renaissance School of Medicine
### @@@ Kristin Pasquarello, PA – St. Francis Hospital ### 2235120###Panel Discussant###Administrative Director###St. Francis Hospital###
Panel Discussant: Kristin Pasquarello, PA – St. Francis Hospital
###
Discussion

Rasha Al-Lamee, MA, MD, PhD – Imperial College London ### 195289###Panel Moderator###Interventional Cardiology Consultant###Imperial College London###
Panel Moderator: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
### @@@ Arasi Maran, MD – Medical University of South Carolina ### 469065###Panel Moderator###Associate Professor###Medical University of South Carolina###
Panel Moderator: Arasi Maran, MD – Medical University of South Carolina
### @@@ Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital ### 1880527###Panel Discussant###Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati ###The Christ Hospital###
Panel Discussant: Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital
### she/her/hers @@@ Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center ### 318231###Panel Discussant###Director of Intravascular Imaging###St. Francis Hospital - The Heart Center###
Panel Discussant: Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center
### @@@ Angela M. Taylor, MD, MS, MBA – University of Virginia ### 555069###Panel Discussant###Professor ###University of Virginia###
Panel Discussant: Angela M. Taylor, MD, MS, MBA – University of Virginia
###
Discussion

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai, New York ### 163212###Panel Moderator###Director, The Women’s Heart and Vascular Center at Mount Sinai Heart Director, The Center for Interventional Cardiovascular Research and Clinical Trials Endowed Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes Professor of Medicine (Cardiology) Professor of Population Health Science and Policy ###Icahn School of Medicine at Mount Sinai, New York###
Panel Moderator: Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai, New York
### @@@ Renuka Jain, MD – Aurora St. Luke's ### 2235124###Panel Discussant###Director of Echocardiography ###Aurora St. Luke's###
Panel Discussant: Renuka Jain, MD – Aurora St. Luke's
### @@@ Puja B. Parikh, MD, MPH – Stony Brook University Renaissance School of Medicine ### 195305###Panel Discussant###Director, Transcatheter Aortic Valve Replacement Program; Associate Professor of Medicine with Tenure###Stony Brook University Renaissance School of Medicine###
Panel Discussant: Puja B. Parikh, MD, MPH – Stony Brook University Renaissance School of Medicine
### @@@ Kristin Pasquarello, PA – St. Francis Hospital ### 2235120###Panel Discussant###Administrative Director###St. Francis Hospital###
Panel Discussant: Kristin Pasquarello, PA – St. Francis Hospital
###
Discussion

Rasha Al-Lamee, MA, MD, PhD – Imperial College London ### 195289###Panel Moderator###Interventional Cardiology Consultant###Imperial College London###
Panel Moderator: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
### @@@ Arasi Maran, MD – Medical University of South Carolina ### 469065###Panel Moderator###Associate Professor###Medical University of South Carolina###
Panel Moderator: Arasi Maran, MD – Medical University of South Carolina
### @@@ Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital ### 1880527###Panel Discussant###Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati ###The Christ Hospital###
Panel Discussant: Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital
### she/her/hers @@@ Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center ### 318231###Panel Discussant###Director of Intravascular Imaging###St. Francis Hospital - The Heart Center###
Panel Discussant: Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center
### @@@ Angela M. Taylor, MD, MS, MBA – University of Virginia ### 555069###Panel Discussant###Professor ###University of Virginia###
Panel Discussant: Angela M. Taylor, MD, MS, MBA – University of Virginia
###
Discussion

Suzanne J. Baron, MD, MSc – Massachusetts General Hospital ### 195293###Panel Moderator###Interventional Cardiologist###Massachusetts General Hospital###
Panel Moderator: Suzanne J. Baron, MD, MSc – Massachusetts General Hospital
### @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Moderator###Professor of Medicine ###Yale School of Medicine###
Panel Moderator: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
### @@@ Allison Dupont, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 880570###Panel Discussant###Interventional Cardiologist###Northside Cardiovascular Institute###
Panel Discussant: Allison Dupont, MD, FACC, FSCAI – Northside Cardiovascular Institute
### @@@ Srihari S. Naidu, MD, FSCAI – Westchester Medical Center ### 163225###Panel Discussant###Director, Cath Labs and HCM Program###Westchester Medical Center###
Panel Discussant: Srihari S. Naidu, MD, FSCAI – Westchester Medical Center
### @@@ Olga Toleva, MD, MPH – Georgia Heart Institute ### 1534232###Panel Discussant###Lead of Advanced Coronary Physiology Program###Georgia Heart Institute###
Panel Discussant: Olga Toleva, MD, MPH – Georgia Heart Institute
### @@@ Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 1222247###Panel Discussant###Attending Physician###Northside Cardiovascular Institute###
Panel Discussant: Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute
###
Discussion

Rasha Al-Lamee, MA, MD, PhD – Imperial College London ### 195289###Panel Moderator###Interventional Cardiology Consultant###Imperial College London###
Panel Moderator: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
### @@@ Arasi Maran, MD – Medical University of South Carolina ### 469065###Panel Moderator###Associate Professor###Medical University of South Carolina###
Panel Moderator: Arasi Maran, MD – Medical University of South Carolina
### @@@ Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital ### 1880527###Panel Discussant###Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati ###The Christ Hospital###
Panel Discussant: Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital
### she/her/hers @@@ Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center ### 318231###Panel Discussant###Director of Intravascular Imaging###St. Francis Hospital - The Heart Center###
Panel Discussant: Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center
### @@@ Angela M. Taylor, MD, MS, MBA – University of Virginia ### 555069###Panel Discussant###Professor ###University of Virginia###
Panel Discussant: Angela M. Taylor, MD, MS, MBA – University of Virginia
###
Discussion & Wrap Up

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Speaker###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Speaker: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
###
Discussion and Q&A

Raymond Townsend, MD (he/him/his) – University of Pennsylvania ### 188314###Panel Moderator###Professor###University of Pennsylvania###
Panel Moderator: Raymond Townsend, MD (he/him/his) – University of Pennsylvania
### he/him/his @@@ David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute ### 163153###Panel Discussant###Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare###Piedmont Heart Institute###
Panel Discussant: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute
### @@@ David P. Lee, MD – Stanford University ### 484979###Panel Discussant###Professor of Medicine###Stanford University###
Panel Discussant: David P. Lee, MD – Stanford University
### @@@ Felix Mahfoud, MD – Saarland University Hospital ### 188311###Panel Discussant###Professor###Saarland University Hospital###
Panel Discussant: Felix Mahfoud, MD – Saarland University Hospital
### @@@ Andrew SP Sharp, MD – University Hospital of Wales ### 952803###Panel Discussant###Consultant Cardiologist###University Hospital of Wales###
Panel Discussant: Andrew SP Sharp, MD – University Hospital of Wales
###
Discussion: Is There a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

Alexandre A. Abizaid, MD, PhD – Incor ### 162997###Panel Moderator###Director of Invasive Cardiology###Incor###
Panel Moderator: Alexandre A. Abizaid, MD, PhD – Incor
### @@@ Michael H. Joner, MD – Deutsches Herzzentrum Muenchen ### 163150###Panel Moderator###Associate Professor Interventional Cardiology###Deutsches Herzzentrum Muenchen###
Panel Moderator: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen
### @@@ Yoshinobu Onuma, MD, PhD (he/him/his) – University of Galway ### 163238###Panel Moderator###Professor of Interventional Cardiology###University of Galway###
Panel Moderator: Yoshinobu Onuma, MD, PhD (he/him/his) – University of Galway
### he/him/his @@@ Sandeep Basavarajaiah, MD ### 1894440###Panel Discussant#########
Panel Discussant: Sandeep Basavarajaiah, MD
### @@@ David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Panel Discussant###Professor, Consultant Interventional Cardiology###Lund University###
Panel Discussant: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his @@@ Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH ### 185856###Panel Discussant###Director of the Heart & Vascular Center###Rheinland Klinikum Neuss GmbH###
Panel Discussant: Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH
### @@@ Semih Oktay, PhD – Cardiomed Device Consultants ### 163236###Panel Discussant###President###Cardiomed Device Consultants###
Panel Discussant: Semih Oktay, PhD – Cardiomed Device Consultants
### @@@ Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons ### 163242###Panel Discussant###Associate Professor of Medicine###Columbia University Vagelos College of Physicians and Surgeons###
Panel Discussant: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons
### @@@ Richard J. Rapoza, PhD – Abbott Vascular ### 163254###Panel Discussant###Divisional Vice President, Global Research and Development###Abbott Vascular###
Panel Discussant: Richard J. Rapoza, PhD – Abbott Vascular
### @@@ Pieter C. Smits, PhD, FESC (he/him/his) – CERC (Cardiovascular European Research Center) ### 242821###Panel Discussant###Medical Director ###CERC (Cardiovascular European Research Center)###
Panel Discussant: Pieter C. Smits, PhD, FESC (he/him/his) – CERC (Cardiovascular European Research Center)
### he/him/his @@@ Ruben Yannick Gerold Tijssen, MD, PhD (he/him/his) – St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam ### 500123###Panel Discussant###MD, PhD###St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam###
Panel Discussant: Ruben Yannick Gerold Tijssen, MD, PhD (he/him/his) – St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam
### he/him/his
Discussion Panel

Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration ### 163054###Panel Moderator###Deputy Director, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Panel Moderator: Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration
### @@@ Changfu Wu, PhD – Food and Drug Administration ### 184772###Panel Moderator###SBRBPAS Expert###Food and Drug Administration###
Panel Moderator: Changfu Wu, PhD – Food and Drug Administration
### @@@ David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Panel Discussant###Professor, Consultant Interventional Cardiology###Lund University###
Panel Discussant: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his @@@ Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration ### 163094###Panel Discussant###Chief Medical Officer, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Panel Discussant: Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Panel Discussant###Professor of Medicine###Beth Israel Deaconess Medical Center###
Panel Discussant: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
### @@@ Graeme Hickey ### 2273347###Panel Discussant#########
Panel Discussant: Graeme Hickey
### @@@ Josh Smale ### 1886688###Panel Discussant#########
Panel Discussant: Josh Smale
### @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Panel Discussant###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Panel Discussant: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
###
Discussion Panel

Dominic Allocco, MD, MS – Boston Scientific ### 914909###Panel Moderator###Vice President, Clinical###Boston Scientific###
Panel Moderator: Dominic Allocco, MD, MS – Boston Scientific
### @@@ Jennifer Rymer, MD – Duke ### 1247764###Panel Moderator###Interventional cardiologist###Duke###
Panel Moderator: Jennifer Rymer, MD – Duke
### @@@ Roberta Chapman ### 2273353###Panel Discussant#########
Panel Discussant: Roberta Chapman
### @@@ Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute ### 194917###Panel Discussant###Vice Chief of Cardiology and Director of Structural Heart Program###The Erlanger Heart and Lung Institute###
Panel Discussant: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute
### @@@ Alexander C. Fanaroff, MD, MHS – University of Pennsylvania ### 1835468###Panel Discussant###Assistant Professor of Medicine###University of Pennsylvania###
Panel Discussant: Alexander C. Fanaroff, MD, MHS – University of Pennsylvania
### @@@ Michael R. Jaff, DO – Boston Scientific Corporation ### 163148###Panel Discussant###Chief Medical Officer###Boston Scientific Corporation###
Panel Discussant: Michael R. Jaff, DO – Boston Scientific Corporation
### @@@ Dan Stephens ### 2273354###Panel Discussant#########
Panel Discussant: Dan Stephens
### @@@ Michelle Tarver ### 2273352###Panel Discussant#########
Panel Discussant: Michelle Tarver
###
Discussion Panel

C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Panel Moderator###Professor of Medicine###Beth Israel Deaconess Medical Center###
Panel Moderator: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
### @@@ Rebecca Torguson, MPH – FDA ### 163318###Panel Moderator###Division Director###FDA###
Panel Moderator: Rebecca Torguson, MPH – FDA
### @@@ David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Panel Discussant###Professor, Consultant Interventional Cardiology###Lund University###
Panel Discussant: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his @@@ Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center ### 163113###Panel Discussant###Professor Of Medicine###Penn State University/Hershey Medical Center###
Panel Discussant: Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center
### he/him/his @@@ Nicole Gillette – FDA ### 685424###Panel Discussant###Assistant Director###FDA###
Panel Discussant: Nicole Gillette – FDA
### @@@ Graeme Hickey ### 2273347###Panel Discussant#########
Panel Discussant: Graeme Hickey
### @@@ Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc ### 163295###Panel Discussant###EVP Chief Medical Officer ###Abiomed Inc###
Panel Discussant: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
### @@@ James E. Tcheng, MD – Duke University Health System ### 193467###Panel Discussant###Professor###Duke University Health System###
Panel Discussant: James E. Tcheng, MD – Duke University Health System
###
Discussion: Priorities for Collaboration & Cardiogenic Shock Evidence 2024

Kathleen Grunder ### 2273508###Panel Moderator#########
Panel Moderator: Kathleen Grunder
### @@@ Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Panel Moderator###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Panel Moderator: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Nicole Gillette – FDA ### 685424###Panel Discussant###Assistant Director###FDA###
Panel Discussant: Nicole Gillette – FDA
### @@@ Timothy D. Henry, MD – The Christ Hospital ### 163134###Panel Discussant###Director, The Carl and Edyth Lindner Center for Research and Education###The Christ Hospital###
Panel Discussant: Timothy D. Henry, MD – The Christ Hospital
### @@@ Mariell Jessup ### 204268###Panel Discussant#########
Panel Discussant: Mariell Jessup
### @@@ Harish Lecamwasam ### 2273541###Panel Discussant#########
Panel Discussant: Harish Lecamwasam
### @@@ Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc ### 163295###Panel Discussant###EVP Chief Medical Officer ###Abiomed Inc###
Panel Discussant: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
### @@@ Ernest Spitzer, MD – Cardialysis B.V. ### 1299623###Panel Discussant###Chief Executive Officer###Cardialysis B.V.###
Panel Discussant: Ernest Spitzer, MD – Cardialysis B.V.
###
Discussion: Priorities for Registry-Based Shock Evidence 2024

Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Panel Moderator###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Panel Moderator: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
### @@@ Nicole Gillette – FDA ### 685424###Panel Moderator###Assistant Director###FDA###
Panel Moderator: Nicole Gillette – FDA
### @@@ Andrew D. Althouse, PhD – Medtronic ### 851258###Panel Discussant###Senior Principal Statistician###Medtronic###
Panel Discussant: Andrew D. Althouse, PhD – Medtronic
### @@@ Mariell Jessup ### 204268###Panel Discussant#########
Panel Discussant: Mariell Jessup
### @@@ Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Panel Discussant###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Panel Discussant: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Harish Lecamwasam ### 2273541###Panel Discussant#########
Panel Discussant: Harish Lecamwasam
### @@@ Mauro Moscucci, MD, MBA, MPH – Food and Drug Administration, Center for Devices and Radiological Health ### 914908###Panel Discussant###Medical Officer###Food and Drug Administration, Center for Devices and Radiological Health###
Panel Discussant: Mauro Moscucci, MD, MBA, MPH – Food and Drug Administration, Center for Devices and Radiological Health
### @@@ Christine Rutan ### 1299610###Panel Discussant#########
Panel Discussant: Christine Rutan
### @@@ Shashank S. Sinha, MD, MSc – Inova Heart and Vascular Institute ### 1570668###Panel Discussant###Director, Cardiac ICU; Director, Cardiovascular Critical Care Research###Inova Heart and Vascular Institute###
Panel Discussant: Shashank S. Sinha, MD, MSc – Inova Heart and Vascular Institute
###
Discussion: Priorities for Structured DEI Enhancement in Shock Studies

Dominic Allocco, MD, MS – Boston Scientific ### 914909###Panel Moderator###Vice President, Clinical###Boston Scientific###
Panel Moderator: Dominic Allocco, MD, MS – Boston Scientific
### @@@ Timothy D. Henry, MD – The Christ Hospital ### 163134###Panel Moderator###Director, The Carl and Edyth Lindner Center for Research and Education###The Christ Hospital###
Panel Moderator: Timothy D. Henry, MD – The Christ Hospital
### @@@ Andrew D. Althouse, PhD – Medtronic ### 851258###Panel Discussant###Senior Principal Statistician###Medtronic###
Panel Discussant: Andrew D. Althouse, PhD – Medtronic
### @@@ Paul Coplan ### 2273543###Panel Discussant#########
Panel Discussant: Paul Coplan
### @@@ Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute ### 194917###Panel Discussant###Vice Chief of Cardiology and Director of Structural Heart Program###The Erlanger Heart and Lung Institute###
Panel Discussant: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute
### @@@ Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration ### 163094###Panel Discussant###Chief Medical Officer, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Panel Discussant: Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Mariell Jessup ### 204268###Panel Discussant#########
Panel Discussant: Mariell Jessup
###
Discussion: What Directions and Working Groups Best Fit Shock Evidence Priorities for 2024?

Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Moderator###Director Office of CV Devices###U.S. Food and Drug Administration###
Moderator: Bram Zuckerman, MD – U.S. Food and Drug Administration
### @@@ Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Moderator###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Moderator: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Panel Discussant###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Panel Discussant: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
### @@@ Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration ### 163094###Panel Discussant###Chief Medical Officer, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Panel Discussant: Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Nicole Gillette – FDA ### 685424###Panel Discussant###Assistant Director###FDA###
Panel Discussant: Nicole Gillette – FDA
### @@@ Mariell Jessup ### 204268###Panel Discussant#########
Panel Discussant: Mariell Jessup
### @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Panel Discussant###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Panel Discussant: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
###
Dislodged Coronary Stent Management

Aaphtaab Dheendsa, MD – St. Francis Medical Center ### 2228574###Speaker###Internal Medicine###St. Francis Medical Center###
Speaker: Aaphtaab Dheendsa, MD – St. Francis Medical Center
###
Disparities in Aortic Stenosis Care

Aaron Horne, Jr., MD, MBA – Summit Health ### 457690###Speaker###Structural Interventionalist###Summit Health###
Speaker: Aaron Horne, Jr., MD, MBA – Summit Health
###
Disparities in CLTI Treatment and Outcomes

Eleni Whatley, PhD – FDA ### 317148###Speaker###Biomedical Engineer###FDA###
Speaker: Eleni Whatley, PhD – FDA
###
DISPARITIES IN PAD AND STRUCTURAL HEART

Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Moderator###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Moderator: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
### @@@ Joaquin E. Cigarroa, MD – OHSU Knight Cardiovascular Institute ### 914907###Moderator###Head of the Division of Cardiovascular Medicine###OHSU Knight Cardiovascular Institute###
Moderator: Joaquin E. Cigarroa, MD – OHSU Knight Cardiovascular Institute
### @@@ Aaron Horne, Jr., MD, MBA – Summit Health ### 457690###Moderator###Structural Interventionalist###Summit Health###
Moderator: Aaron Horne, Jr., MD, MBA – Summit Health
### @@@ Misti Malone, PhD (she/her/hers) – FDA ### 201905###Moderator###Asst Director, PIDT###FDA###
Moderator: Misti Malone, PhD (she/her/hers) – FDA
### she/her/hers
Disparities: Inequalities in Interventional Cardiology and Healthcare

Biljana Parapid, MD, PhD (she/her/hers) – Belgrade University School of Medicine ### 675739###Speaker###Assistant Professor, Department of Medicine - Cardiology###Belgrade University School of Medicine###
Speaker: Biljana Parapid, MD, PhD (she/her/hers) – Belgrade University School of Medicine
### she/her/hers
Disparities: Inequalities in Interventional Cardiology and Healthcare Career Transitions

Michael A. Kutcher, MD – Wake Forest University School of Medicine ### 817384###Speaker###Emeritus Professor of Cardiovascular Medicine###Wake Forest University School of Medicine###
Speaker: Michael A. Kutcher, MD – Wake Forest University School of Medicine
###
Diversity, Equity & Inclusion in CV Device Evaluation

Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Panel Discussant###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Panel Discussant: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
### @@@ Brittany Caldwell ### 2273349###Panel Discussant#########
Panel Discussant: Brittany Caldwell
### @@@ Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute ### 194917###Panel Discussant###Vice Chief of Cardiology and Director of Structural Heart Program###The Erlanger Heart and Lung Institute###
Panel Discussant: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute
### @@@ Michael R. Jaff, DO – Boston Scientific Corporation ### 163148###Panel Discussant###Chief Medical Officer###Boston Scientific Corporation###
Panel Discussant: Michael R. Jaff, DO – Boston Scientific Corporation
### @@@ Jennifer Rymer, MD – Duke ### 1247764###Panel Discussant###Interventional cardiologist###Duke###
Panel Discussant: Jennifer Rymer, MD – Duke
### @@@ Dan Stephens ### 2273354###Panel Discussant#########
Panel Discussant: Dan Stephens
###
Diversity, Equity & Inclusion in CV Device Evaluation
Do We Know Anything More About Pulmonary Embolism Diagnosis and Management Now than We Did in 2004?

Michael R. Jaff, DO – Boston Scientific Corporation ### 163148###Speaker###Chief Medical Officer###Boston Scientific Corporation###
Speaker: Michael R. Jaff, DO – Boston Scientific Corporation
###
Does Fractional Flow Reserve Impact On Clinical Outcomes? Findings From A Systematic Review(n=56,185) And Meta-analysis

Andrea Teira Calderón, MD (she/her/hers) – Hospital Universitari i Politecnic La Fe ### 2234312###Speaker###Interventional Cardiology Fellow###Hospital Universitari i Politecnic La Fe###
Speaker: Andrea Teira Calderón, MD (she/her/hers) – Hospital Universitari i Politecnic La Fe
### she/her/hers
Does PCI Improve Symptoms in Stable Coronary Artery Disease? Data from ORBITA and ORBITA-2

Rasha Al-Lamee, MA, MD, PhD – Imperial College London ### 195289###Speaker###Interventional Cardiology Consultant###Imperial College London###
Speaker: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
###
Does The Outcome Of Heart Failure Patients After Tavi Differ Whether They Have Normal Or Reduced Ventricular Function?

Elisha James Ouzan, MD (he/him/his) – Hadassah Hebrew University Medical Center ### 1872211###Speaker###Previous director Of Cardiology department of hospitalization###Hadassah Hebrew University Medical Center###
Speaker: Elisha James Ouzan, MD (he/him/his) – Hadassah Hebrew University Medical Center
### he/him/his
Donor Vessel Injury

Rajan Patel, MD (he/him/his) – Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland ### 485076###Speaker###Interventional Cardiology Fellowship Program Director & Medical Director CTO PCI program###Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland###
Speaker: Rajan Patel, MD (he/him/his) – Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland
### he/him/his
Don’t Discount the Microvascular Dysfunction

Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital ### 1880527###Speaker###Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati ###The Christ Hospital###
Speaker: Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital
### she/her/hers
Doppler and Thermodilution Measured Flow are Not the Same but Close

Megha Prasad, MD – Columbia university ### 1432184###Speaker###Assistant professor###Columbia university###
Speaker: Megha Prasad, MD – Columbia university
###
Dorsal Radial Access: Now a Legitimate Access

Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center ### 163113###Speaker###Professor Of Medicine###Penn State University/Hershey Medical Center###
Speaker: Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center
### he/him/his
Double Trouble – Management of Cardiogenic Shock in the PeriPartum Period

Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 1222247###Speaker###Attending Physician###Northside Cardiovascular Institute###
Speaker: Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute
###
DREAMS 3G Including New Vasomotion Data

Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH ### 185856###Speaker###Director of the Heart & Vascular Center###Rheinland Klinikum Neuss GmbH###
Speaker: Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH
###
Drug Coated Balloon Angioplasty For Bifurcations Is Favourable To Drug Eluding Stents In A Retrospective Propensity Matched Cohort

Natasha Corballis, MRes – Norwich Medical School/ Norfolk and Norwich University Hospital ### 2234296###Speaker###Research fellow###Norwich Medical School/ Norfolk and Norwich University Hospital###
Speaker: Natasha Corballis, MRes – Norwich Medical School/ Norfolk and Norwich University Hospital
###
DRUG-COATED BALLOONS IN DAILY PRACTICE: INSIGHTS FROM LATIN AMERICAN EXPERIENCES

Alexandre A. Abizaid, MD, PhD – Incor ### 162997###Moderator###Director of Invasive Cardiology###Incor###
Moderator: Alexandre A. Abizaid, MD, PhD – Incor
### @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Moderator###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
### @@@ Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare ### 242825###Panel Discussant###consultant Cardiologist###Fondazione Ricerca e Innovazione Cardiovascolare###
Panel Discussant: Bernardo Cortese, MD, FESC, FSCAI (he/him/his) – Fondazione Ricerca e Innovazione Cardiovascolare
### he/him/his @@@ Azeem Latib, MD – Montefiore Medical Center ### 163182###Panel Discussant###Director, Interventional Cardiology & Structural Heart Interventions###Montefiore Medical Center###
Panel Discussant: Azeem Latib, MD – Montefiore Medical Center
### @@@ Alfredo E. Rodriguez, MD,PhD – Otamendi Hospital ### 1418725###Panel Discussant###Director Cardiac Unit ###Otamendi Hospital###
Panel Discussant: Alfredo E. Rodriguez, MD,PhD – Otamendi Hospital
###
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty for In-Stent Restenosis: A Nationwide Segment-Level Analysis from SCAAR of 7987 Patients

David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Speaker###Professor, Consultant Interventional Cardiology###Lund University###
Speaker: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his
Drug-Coated Devices: Is Limus the Pathway Forward?

Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center ### 653443###Speaker###Director of Vascular Intervention###Beth Israel Deaconess Medical Center###
Speaker: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center
###
Dual Tip-in Technique For A Complex Right Coronary Artery Complete Total Occlusion

Maruf Sarwar, MD – White River Health Medical Center ### 2234233###Speaker###Internal Medicine Resident###White River Health Medical Center###
Speaker: Maruf Sarwar, MD – White River Health Medical Center
###
Dual Tip-in Technique For A Complex Right Coronary Artery Complete Total Occlusion

Maruf Sarwar, MD – White River Health Medical Center ### 2234233###Speaker###Internal Medicine Resident###White River Health Medical Center###
Speaker: Maruf Sarwar, MD – White River Health Medical Center
###
Dual Wire Technique For Transseptal Passage Of Intracardiac Echocardiogram Probe During Left Atrium Appendage Closure

Luis Augusto Palma Dallan, MD, PhD – University Hospitals Cleveland Medical Center ### 670536###Speaker###Physician###University Hospitals Cleveland Medical Center###
Speaker: Luis Augusto Palma Dallan, MD, PhD – University Hospitals Cleveland Medical Center
###
Durability of Surgical and Transcatheter Valves: What Do We Know So Far?

Stephanie Sellers, PhD (she/her/hers) – University of British Columbia ### 2199559###Speaker###Assistant Professor###University of British Columbia###
Speaker: Stephanie Sellers, PhD (she/her/hers) – University of British Columbia
### she/her/hers
DurAVR Biomimetic Transcatheter Heart Valve: Early Feasibility Study (EFS) Update

Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI – US Heart & Vascular, Tucson Medical Center ### 1432202###Speaker###Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.###US Heart & Vascular, Tucson Medical Center###
Speaker: Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI – US Heart & Vascular, Tucson Medical Center
###
DurAVR Biomimetic Transcatheter Heart Valve: Results From The First-in-human And US Early Feasibility Studies

Rishi Puri, MBBS PhD FRACP – Cleveland Clinic ### 467899###Speaker###Staff Structural and Coronary Interventionalist###Cleveland Clinic###
Speaker: Rishi Puri, MBBS PhD FRACP – Cleveland Clinic
###
DynamX Bioadaptor: The Next Major Advance to Restore Vessel Function?

Dean J. Kereiakes, MD, FACC, MSCAI (he/him/his) – The Christ Hospital Health Network ### 163163###Speaker###President, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University###The Christ Hospital Health Network###
Speaker: Dean J. Kereiakes, MD, FACC, MSCAI (he/him/his) – The Christ Hospital Health Network
### he/him/his